Beatrice Guerrier-Pilarte


Advanced Nurse Practitioner and Certified Nurse Midwife

Highly focused and knowledgeable professional with experience in providing a Full spectrum of excellent Womens health care within a private clinic and hospital setting. Provide primary and specialty care for women, diagnosing, trying, and managing the care of women with acute and chronic illnesses. HPV screening and vaccinations. Conducting physical examinations and interpreting medical history, ordering and managing care based on diagnostic tests and procedures. Delivering babies and attend ing to pregnancy-related issues. Providing care to women from puberty through menopause, including newborn care. Prescribing pharmacologic treatment. Counseling and educating clients Practices in collaboration with obstetricians & Gynecologists.

Previous Registered Nurse

Highly skilled career professional with 19 years of practical experience in Labor Delivery on a moderate to high-risk unit intermittent charge nurse position that facilitates a safe work environment, liaison between nurses and physicians and serves as a link in the chain of command Manages maternal and fetal status from admission to postpartum Cross-trained for OB Operating Room Surgical Scrub Technician Preceptor for new perinatal nurses Proficient in collaboration with a multidisciplinary team to provide all aspects of perinatal care Consistent recipient of Palmetto General Hospital ‘s Honor Roll Labor and Delivery Nurse of the Year at Palmetto General Hospital 2007.


Licensed and Board Certified Advanced Registered Nurse Practitioner and Certified Nurse Midwife, January 2013

Permanent Florida License ARNP 2729712

Basic Life Support (BLS) Ce1tified

Advanced Cardiac Life Support (ACLS) Ce1tified

Neonatal Resuscitation Provider (NRP) Certified

Advanced Fetal Monitoring Certified

Certified Biomedical Researcher for Cord Use public cord banking

Certified in Vaginal & Cervical Colposcopy

National Provider Identifier (NPI) 1346681202

Certified Research Coordinator


2016 – Present – Doral Medical Research, LLC

2015 – 2016 – Universal Clinical Research Associates

3/2013 – Present –  Dr. Victoria Garcia & Associates Advanced Registered Nurse Practitioner Certified Nurse Midwife

8/2012-3 /2 013 – Memorial Miramar Hospital, Miramar , Florida Registered Nurse

6/1993-3/2013 – Palmetto General Hospital, Hia leah, F lorid a Regist e red Nurse


8/2010-3/2012 – Frontier Nursing University Hyden, Kentucky Masters in Advanced Registered Nurse Practice Masters in Midwifery

1/2009-1/2010 – University of Phoenix (Online Education) Phoenix, Arizona Masters in Nursing Administration

8/2008-6/2009 – Nova Southeastern University Davie, Florida Bachelor of Science in Nursing

8/1990 -6/1993 – Miami Dade Community College Miami, Florida Associates of Science in Nursing

9/1986-6/1989 – Norland Senior High School Miami, Florida High School Diploma



Palmetto General Hospital





Sub Investigator

Bayer Pharmaceuticals: A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of XXXXX in subjects with uterine fibroids. 2018

Myovant Sciences: An international Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate XXXXX CoAdministered with ad without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids. 2017

Bayer Pharmaceuticals: An openlabel, parallel-group, randomized, multicenter study to assess the safety and efficacy of XXXXX in subjects with uterine fibroids versus standard of care. 2017 NCT03194646

AbbVie: Phase III Fibroid Study; Menstrual flow research to XXX medication versus Placebo 01/2016

Merck Sharp & Dohme Corp: A Phase 2a, Proof of Concept, Randomized, Doubleblind Placebo-controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK7264 in Women with Moderate to Severe Endometriosis-related Pain. 2018

Janssen Pharmaceuticals: A Randomized, Double-blind, Placebo-controlled, First-in-Human, Phase l/2a/2b Study to Evaluate Safety, Reactogenicity, Regimen Immunogenicity and Efficacy of Monovalent HPV16 and HPVl 8 Ad26-vectored Vaccine Components and an MVA-vectored HPV16/18 Vaccine Component in Otherwise Healthy Women with Persistent HPV16 or 18 Infection of the Cervix. 2019